This directory serves as a resource listing of active biotech that develop therapeutics, diagnostics and/or medtech. The companies listed in this directory are not representative of the companies that are active members of the Biotech and Money community.
Add / Amend your company listing for free
(only active biotech ie. therapeutic, diagnostic and medtech companies are eligible for listing)
Russia
Allopharm is a biopharmaceutical company which discovers synthetic and naturally occurring peptides related to insect immunity and to develop innovative antiviral, antibacterial and antitumoral pharmaceuticals and skin care products. Company's lead product Allomedin
BBU Pharmaceuticals develops a new generation Parkinson?s disease drug BDG-DOPAMINE
Fusion Pharma is a small innovative company with main focus on computer aided drug design and medicinal chemistry.
Hepatera is a private Russian biotech company conducting evaluation of promising drug candidates, as well as development and bringing to the Russian market safe and effective drugs for the treatment of liver diseases. First product (Myrcludex B) is aimed at the treatment of chronic
hepatitis B and D.
hepatitis B and D.
Russian Company LLC Incuron was created in January 2010 by private mutual fund with high-risk venture investments from Bioprocess Capital Ventures cooperative with American Public Company Cleveland Biolabs, Inc.
Incuron develop the innovative class of drug substance (curaxins) for oncological and autoimmune treatment diseases. Incuron carry on business in Russia and USA. All of the companies products exhibit worldwide capacity properties and are capable of changing over obtain therapy for estimate oncological diseases.
Incuron develop the innovative class of drug substance (curaxins) for oncological and autoimmune treatment diseases. Incuron carry on business in Russia and USA. All of the companies products exhibit worldwide capacity properties and are capable of changing over obtain therapy for estimate oncological diseases.
Quantum develops small molecule drug candidates in several areas: cancer (cancer metabolism, angiogenesis and metastasis inhibitors), HIV, antibiotics and neuroprotection with the main focus on early stage of development up to human proof of concept. Quantum has advanced proprietary computational technology that helps to design novel drug candidates against most challenging targets quickly and cost-effectively . The company has a good track record in successful collaborations with leading research institutes and biotech from the US. Quantum Pharmaceuticals? projects are supported by grants from Skolkovo foundation and the Ministry of Industry and Trade of the Russian Federation.
Quantum Pharmaceuticals is a subsidiary, R&D arm, of the one of the largest pharmaceutical companies in Russia, Valenta Pharmaceuticals
They are looking for partners for co-development of products worldwide or out-licensing it, as well exploring funding opportunities to take us from our late preclinical/proof of concept (PoC) in animals development stage to achieve the PoC in humans as quickly as possible.
More details http://tinyurl.com/lez8yly
Quantum Pharmaceuticals is a subsidiary, R&D arm, of the one of the largest pharmaceutical companies in Russia, Valenta Pharmaceuticals
They are looking for partners for co-development of products worldwide or out-licensing it, as well exploring funding opportunities to take us from our late preclinical/proof of concept (PoC) in animals development stage to achieve the PoC in humans as quickly as possible.
More details http://tinyurl.com/lez8yly
SOTIO is a biotechnology company that is developing a next generation Active Cellular Immunotherapy (?ACI?), focusing on the treatment of cancer and autoimmune diseases. The company is in the process of developing new medical therapies using an immunotherapy platform based on activated dendritic cells with the view to significantly improving these treatments and making them available to patients.